cromolyn sodium has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barocelli, E; Cattaruzza, F; Cenac, N; Hyun, E; Impicciatore, M; Sternini, C; Vergnolle, N | 1 |
1 other study(ies) available for cromolyn sodium and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
| Article | Year |
|---|---|
Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Capsaicin; Cromolyn Sodium; Female; Gastrointestinal Motility; Intestinal Mucosa; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurokinin-1 Receptor Antagonists; Oligopeptides; Peptide Fragments; Rats; Rats, Wistar; Receptor, PAR-2; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Visceral Afferents | 2006 |